Factors, associated with effective control of arterial hypertension in the general working-age population

Objective. To analyze determinants and their contribution to efficiency of arterial hypertension (AH) control in the hypertensive population.

Design and methods. In the cross-sectional study a total of 334 men and 436 women derived from a representative sample of the general population aged 25–64 years, meeting criteria for AH, were examined. All subjects signed voluntary informed consent to participate in the study. A standard questionnaire based on adapted international methods was used. The associative analysis included sets of socioeconomic, behavioral, psychosocial, medical and biological variables. We used univariable (χ², Fisher exact test, Student’s t-test, Mann–Whitney test) and multivariable statistics (logistic regression). Effective AH control was considered in case of blood pressure (BP) < 140/90 mm Hg. Probabilities of error < 5% were considered statistically significant.

Results. Irrespective of gender, use of hypotensive drugs was the most influential factor in ensuring effective control of AH in the population. A major barrier to reaching target BP levels in women was the number of current metabolic risk factors (RF). Age (more significant in men), general obesity (both sexes), history of kidney disease (men), elevated glucose and triglycerides (women) were also associated with ineffective AH control. Angiotensine receptor blockers, angiotensin converting enzyme inhibitors (ACEI), sympatholytics/ spasmolythics in men and ACEI, beta-blockers and diuretics (at moderate or higher affluence only) in women were associated with a higher probability of reaching BP targets. Knowledge of cholesterol level (both sexes), cardiovascular disease, use of statins, reduced quality of life (difficulty with daily activities), sedentary working activity and affluence in men were also associated with effective control of BP.

Conclusions. The data obtained demonstrate that with an increase in the coverage of the hypertensive population with antihypertensive treatment, an increase in the proportion of people reaching the target BP levels may be significant, but still the most important issue is the treatment efficiency. The need to correct behavioral factors that lead to the development of metabolic disorders, especially obesity, but also other RF, remains the most challenging issue in this regard. The findings convince us that it is advisable to take measures to increase awareness of the main cardiovascular disease RF, to involve patients more in controlling their RF, to prescribe statins more frequently, to create conditions for taking antihypertensive drugs in the so-called “mobile” types of working activity, to keep developing infrastructure for mass participation of population in sport activities, and to improve economic conditions.

1. Ford ES, Ajani UA, Croft JB, Critchley JA, Labarthe DR, Kottke TE et al. Explaining the decrease in U.S. deaths from coronary disease, 1980–2000. N Engl J Med. 2007;356(23):238– 2398. doi:10.1056/NEJMsa053935

2. Boytsov SA, Balanova YuA, Shalnova SA, Deev AD, Artamonova GV, Gatagonova TM et al. Arterial hypertension among individuals of 25–64 years old: prevalence, awareness, treatment and control. By the data from ECCE-RF. Cardiovasc Ther Prev. 2014;13(4):4–14. In Russian.

3. Erina AM, Rotar OP, Solntsev VN, Shalnova SA, Deev AD, Baranova EI et al. Epidemiology of arterial hypertension in Russian Federation — importance of choice of criteria of diagnosis. Kardiologiia = Cardiology. 2019;59(6):5–11. In Russian. doi:10.18087/cardio.2019.6.2595

4. Rotar OP, Erina AM, Boyarinova MA, Moguchaya EV, Kolesova EP, Tolkunova KM et al. Hypertension control during the covid 19 pandemic: results of the MMM2021 in Russia. Russ J Cardiol. 2022;27(4):7–13. In Russian. doi:10.15829/1560-4071-2022-5014

5. Chazova IE, Trubacheva IA, Zhernakova YuV, Oshchepkova EV, Serebriakova VN, Kaveshnikov VS. The prevalence of arterial hypertension as a risk factor of cardiovascular diseases in one of the cities in siberian federal district. Sistemnie Gipertenzii = Systemic Hypertensions. 2013;10(4):30–37. In Russian.

6. Troubacheva IA, Perminova OA, Shatrov SV, Karpov RS, Gafarov VV. Knowledge and arterial hypertension in adult population of Tomsk (population sampling study). Sib Med J. 2004;19(4):75–81. In Russian.

7. Krivoshapova KE, Tsygankova DP, Barbarash OL. Prevalence, awareness and adherence to treatment of arterial hypertension: myths and reality. Sistemnie Gipertenzii = Systemic Hypertensions. 2018;15(1):63–67. In Russian.

8. Grinshtein YuI, Petrova MM, Shabalin VV, Ruf RR, BalanovaYuA, Evstifeeva SE et al. The prevalence of arterial hypertension in Krasnoyarsky territory: the data from the epidemiology study ESSE-RF. Arterial’naya Gipertenziya = Arterial Hypertension. 2016;22(6):551–559. In Russian. doi:10.1111/jch.12372

9. Smirnova EA, Terekhovskaya YuV, Molodtsova AA, Yakushin SS, Yepikhina EA, Biryukova ZHA et al. Arterial hypertension in Ryazan region: data of the third section of the EPOHA study. Russ J Cardiol. 2019;24(6):49–53. In Russian. doi:10.15829/1560-4071-2019-6-49-53

10. Balanova YA, Shalnova SA, Imaeva AE, Kapustina AV, Muromtseva GA, Evstifeeva SE et al. Prevalence, awareness, treatment and control of hypertension in Russian Federation (data of observational ESSE-RF 2 study). Rat Pharmacother Cardiol. 2019;15(4):450–466. doi:10.20996/1819-6446-2019-15-4-450-466

11. Balanova YuA, Shalnova SA, Kutsenko VA, Imaeva AE, Kapustina AV, Muromtseva GA et al. Contribution of hypertension and other risk factors to survival and mortality in the Russian population. Cardiovasc Ther Prev. 2021;20(5):164–174. In Russian. doi:10.15829/1728-8800-2021-3003

12. Shalnova SA, KonradiAO, Balanova YuA, Deev AD, Imaeva AE, Muromtseva GA et al. What factors do influence arterial hypertension control in Russia. Cardiovasc Ther Prev. 2018;17(4):53–60. In Russian. doi:10.15829/1728-8800-2018-4-53-60

13. Rotar OP, Tolkunova KM, Solntsev VN, Erina AM, Boyarinova MA, Alieva AS et al. May measurement month 2019: adherence to treatment and hypertension control in Russia. Russ J Cardiol. 2020;25(3):98–108. In Russian. doi:10.15829/1560-4071-2020-3-3745

14. Kaveshnikov VS, Serebryakova VN, Trubacheva IA. Analysis of factors, associated with the probability of antihypertensive medication in the population of patients with arterial hypertension. Russ J Cardiol. 2019;24(6):73–77. In Russian.

15. Kaveshnikov VS, Serebryakova VN, Trubacheva IA. Determinants of arterial hypertension control in the hypertensive population receiving medical therapy. Compl Iss Cardiovasc Dis. 2022;11(1):26–35. In Russian.

16. Rose GA, Blackburn H, Gillum RF, Prineas RJ. Cardiovascular survey methods, 2nd edn. 1982. World Health Organization, Geneva, p. 124–127.

17. Balanova YuA, Kontsevaya AV, Shalnova SA, Deev AD, Kapustina AV, Evstifeeva SE et al. Life quality of persons with arterial hypertension in Russia — is there relation to treatment? (By data from populational study ESSE-RF). Russ J Cardiol. 2016;21(9):7–13. In Russian. doi:10.15829/1560-4071-2016-9-7-13

18. Shalnova SA, Deev AD, Metelskaya VA, Evstifeeva SE, Rotar OP, Zhernakova YuV et al. Awareness and treatment specifics of statin therapy in persons with various cardiovasular risk: the study ESSE-RF. Cardiovas Ther Prev. 2016;15(4):29–37. In Russian. doi:10.15829/1728-8800-2016-4-29-37